Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Swiss pharma industry behind in technology and clinical trials, index shows
By Thomson Reuters Nov 4, 2026 | 6:25 AM ZURICH, Nov 4 (Reuters) – Switzerland's pharmaceutical and chemicals industries are slipping behind when it comes to technology and clinical trials, a yearly Global Industry…
Democratic Sweep Sets Stage for More Pharma Oversight
Democrats won big Tuesday on promises to make American life more affordable, particularly health care costs, but the market was unconvinced that policies will dramatically change pharma fortunes. Policy experts expect that Democrats will build on…
Why pharma firms are going to Earth's orbit in search of new cancer drugs
Roughly 300 miles above our heads, three washing machine-sized capsules are orbiting the Earth. Inside one of them, tiny crystals of a potential cancer drug are being grown in the weightlessness of space. The others are testing heat protection…
Royalty Pharma: Q3 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported third-quarter earnings of $145 million. The New York-based company said it had profit of 26 cents per share. Earnings, adjusted for non-recurring costs, were…
Royalty Pharma (RPRX) Q3 2026 Earnings Call Transcript
Chief Executive Officer and Chairman of the Board - Pablo Legorreta EVP, Head of Research and Investments - Marshall Urist EVP, Chief Financial Officer - Terry Coyne Senior Vice President, Head of Investor Relations and Communications - George…
India's Alembic Pharma profit jumps on strong US sales
By Thomson Reuters Nov 4, 2026 | 4:50 AM Nov 4 (Reuters) – India's Alembic Pharmaceuticals posted an 81% rise in second-quarter profit on Wednesday, helped by strong sales in the US market, sending its shares surging 20%.
India's Aurobindo Pharma's quarterly profit rises by a third on strong US demand
By Thomson Reuters Nov 4, 2026 | 10:27 AM Nov 4 (Reuters) – Indian drugmaker Aurobindo Pharma reported a nearly 33% rise in second-quarter profit on Wednesday, led by strong demand and volume gains in its US market. •…
Aurobindo Pharma's Q2 FY27 net up 32% at ₹1124 cr
Updated - November 04, 2026 at 08:57 PM. Aurobindo Phama's consolidated net profit increased 32.5 per cent at ₹1,124 crore in the second quarter of the current financial year ended September 30, 2026, compared to ₹848 crore in the…
Nuvectis Pharma Q3 Earnings Call Highlights
Nuvectis Pharma NASDAQ: NVCT said its third quarter marked a strategic shift into late-stage development following a licensing agreement with Haisco for ex-China rights to two drug candidates: ciprocopan, also known as NXP100, and NXP200. Chairman…
Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth
Updated - November 04, 2026 at 05:38 PM. Ennature Bio Pharma Limited made its stock market debut on the National Stock Exchange and BSE on Wednesday, November 4, 2026. The company, a demerged division of India Glycols Limited. The company reported…
Astellas Pharma (OTCMKTS:ALPMY) Issues Quarterly Earnings Results
Astellas Pharma (OTCMKTS:ALPMY - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.06), Zacks reports. Astellas…
A CFO's Superpower in a Midterm Election: Planning for Multiple Scenarios
Good morning. Chief financial officers typically steer clear of politics. But in the lead-up to a big U.S election, such as yesterday's vote, they're also in their element, scenario-planning for possible outcomes. For many companies, Election Day…
Urogen Pharma (NASDAQ:URGN) Shares Down 16.3% on Disappointing Earnings
Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock price dropped 16.3% on Wednesday following a dissappointing earnings announcement. The stock traded as low as $29.35 and last traded at $28.80. 252,768 shares changed hands during trading, a…
Ascendis Pharma A/S (ASND) Expected to Release Earnings on Wednesday
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) is anticipated to issue its Q3 2026 results before the market opens on Wednesday, November 11th. Analysts expect the company to post earnings of $0.8940 per share and revenue of $409.37 million…
Urogen Pharma (NASDAQ:URGN) Posts Earnings Results, Misses Estimates By $0.14 EPS
Urogen Pharma (NASDAQ:URGN - Get Free Report) released its earnings results on Wednesday. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of $0.11 by ($0.14), FiscalAI reports. The firm had revenue of $89.00…
Receive a Daily briefing on Pharma Industry News
Get Started